The arrival of Retatrutide ZPHC, at a dosage of 120mg, is sparking considerable excitement within the healthcare community. This innovative dual GIP and GLP-1 receptor medication seems to deliver notable improvements in fat reduction compared to previous therapies. Preliminary clinical trials hav